The FDA this week launched a crackdown on smoking and vaping — ordering the vaping system Juul to be taken off the market and saying its intention to require makers of cigarettes and different tobacco merchandise to scale back the quantity of nicotine in them.
In the meantime, the Supreme Courtroom didn’t announce a ruling in a high-stakes abortion case, but it surely mentioned that non-public well being insurers might restrict the quantity of kidney dialysis care they supply, thus forcing some sufferers onto Medicare.
This week’s panelists are Julie Rovner of KHN, Joanne Kenen of the Johns Hopkins Bloomberg Faculty of Public Well being and Politico, and Rachel Cohrs of Stat.
Among the many takeaways from this week’s episode:
- The FDA has ordered Juul to take away its e-cigarettes from the U.S. market as a result of the corporate’s utility to the company didn’t present sufficient data for regulators to find out whether or not Juul introduced a hazard to customers. The FDA mentioned there have been issues concerning the danger of some dangerous chemical substances leaching from the Juul pods. Juul is predicted to enchantment the FDA determination to the courts.
- Juul helped ignite an explosion in e-cigarette use when it got here in the marketplace, and officers initially thought it could assist people who smoke searching for to kick the cigarette behavior. However the business’s use of flavored tobacco and aggressive advertising and marketing helped gasoline a dramatic rise in use amongst teenagers and led to a regulatory crackdown.
- The Supreme Courtroom this week dominated that employers could decide to make all dialysis therapy out of community of their employees’ well being plans, a choice that might possible drive many sufferers to hunt Medicare protection for his or her kidney issues. The choice was a disappointment for dialysis suppliers, who obtain much less in reimbursements from Medicare than they sometimes get from personal insurance coverage.
- The choice leaves many particulars unresolved and additional authorized fights could possibly be coming. Dialysis suppliers may additionally flip to Congress to ascertain legal guidelines that might prohibit employers from such strikes.
- The Senate is more likely to think about a invoice proposed by Sens. Susan Collins (R-Maine) and Jeanne Shaheen (D-N.H.) that seeks to decrease the price of insulin. The invoice is taken into account extra pleasant to drugmakers than one other measure that handed the Home this 12 months. The Senate invoice seeks to get drugmakers to supply insulin on the value they acquired from Medicare in 2021 by permitting them to bypass rebates and different expensive subsidies paid to pharmacy profit managers and insurance coverage. It might additionally restrict out-of-pocket prices for insured customers to $35.
- Because the Senate strikes nearer to a vote on gun security laws, different efforts are underway to seek out extra funding for applications to assist cope with psychological well being issues. These efforts might assist with campaigns to scale back suicides and home violence, that are additionally usually tied to weapons.
- The Home is launching efforts to move appropriations payments, and the preliminary funding measure for the Division of Well being and Human Providers as soon as once more doesn’t embody the so-called Hyde Modification, a long-standing coverage named for the late Rep. Henry Hyde (R-Unwell.) that bans federal funds from getting used for many abortions. Earlier efforts by the Home to jettison the Hyde Modification didn’t clear the Senate.
- President Joe Biden has nominated Arati Prabhakar, former head of the Protection Superior Analysis Tasks Company (DARPA), to go the White Home Workplace of Science and Know-how Coverage. She would substitute Eric Lander, who was compelled to resign after reviews of workers harassment.
- Prabhakar seems to be a noncontroversial selection and comes with a great deal of administration expertise. Her obligations will possible embody overseeing pandemic planning, efforts to form a brand new biomedical analysis company referred to as ARPA-H, and techniques to boost most cancers prevention.
Additionally this week, Rovner interviews KHN’s Noam N. Levey concerning the new KHN-NPR undertaking on medical debt, referred to as “Analysis: Debt.”
Plus, for further credit score, the panelists suggest their favourite well being coverage tales of the week they suppose you must learn, too:
Julie Rovner: The AP’s “At Westminster Dog Show, New Focus on Veterinarians’ Welfare,” by Jennifer Peltz
Joanne Kenen: Fern.org’s “Back Forty: How to Protect Farmworkers From Heat-Related Kidney Disease,” by Nancy Averett
Rachel Cohrs: The Markup’s “Facebook Is Receiving Sensitive Medical Information From Hospital Websites,” by Todd Feathers, Simon Fondrie-Teitler, Angie Waller, and Surya Mattu
To listen to all our podcasts, click on right here.
Submit a Story Tip